The Pharmaceutical Innovativeness Index: Supporting Value-Based Economic Regulation of Innovative Medicines
Ludmila Peres Gargano, Marcus Carvalho Borin, Wallace Mateus Prata, Juliana Alvares-Teodoro, Francisco de Assis Acurcio, Roberto F. Iunes, Augusto Afonso Guerra · 2025
Read The Pharmaceutical Innovativeness Index: Supporting Value-Based Economic Regulation of Innovative Medicines by Ludmila Peres Gargano, Marcus Carvalho Borin, Wallace Mateus Prata, Juliana Alvares-Teodoro, Francisco de Assis Acurcio, Roberto F. Iunes, Augusto Afonso Guerra (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12733516.txt.
Description
Gargano and co-authors present a tool, published in 2025, for judging how innovative a new medicine really is. Governments that set drug prices must balance fair access with budgets that can last. One pricing approach ties price to the value a drug adds. That needs a clear, open way to grade novelty. The team's index scores new medicines on set domains, so the grading can be checked and repeated.
The authors tested the index's fit for real use through a focus group. Experts in health economics and drug regulation worked through the domains and judged where the tool helps. They also flagged what a fair grading must capture, from clinical gain to wider social impact. The index is offered as support for pricing decisions in Brazil and beyond. It aims to make value-based pricing less arbitrary and more open to debate.
Catalog record
| CREATOR | Ludmila Peres Gargano, Marcus Carvalho Borin, Wallace Mateus Prata, Juliana Alvares-Teodoro, Francisco de Assis Acurcio, Roberto F. Iunes, Augusto Afonso Guerra |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |